About XIEYI Media

Since 2013, based on the "Highland of China's Novel drug thought", TONACEA has started to build a new media matrix, and has carried out multi-level reports on frontier technology, policies and regulations, capital markets, industrial transformation, innovative figures and other bio-innovation related fields. At present, TONACEA continues to serve more than 500 customers.

 

On wechat, TONACEA accounts have accumulated more than 200,000 subscribers, mainly including leaders of government, parks, listed companies, innovative pharmaceutical enterprises, investment institutions, and front-line practitioners. In addition, TONACEA has entered community platforms such as Snowball, Zhihu and Weibo. TONACEA's brand exposure has exceeded 24 million.

图片名称
图片名称

TONACEA

Hot Event Analysis

Subdivision Track Count

Interview of Industry Figures

Think Tank View Output

图片名称
图片名称

XIEYI Release

Enterprise Dynamics

Personnel Change

Product Progress

Policy Release

图片名称
图片名称

TONACEA Biotech

Interpretation of Frontier Achievements

Introduction to Basic Scientific Research

图片名称
图片名称

TONACEA Micro Service

Industrial Activity Information

Theme Live Preview

Recommendation

涨超300%!全球首款外泌体细胞疗法要来了?

曾遭拒的疗法上演惊天逆转

中南大学方丽:AI赋能,穿越生物医药成果转化的“死亡之谷”

A驱区动医药成果转化

以临床数据支持注册,以早期收益反哺研发。

以临床数据支持注册,以早期收益反哺研发。

FDA主任,推开一道疫苗“罗生门”

COVID-19疫苗造成儿童死亡?

in vivo CRA-T,是否可以开启自免新时代?

开启新的时代!

16th医博会丨君联资本王俊峰:中国创新药的航向之问

关乎一个时代产业浪潮的流向与动能

Contact us

图片名称

Contribution and Writing articles

Yu Jing:15521120587

图片名称
图片名称

Media Release

Li Chun:19910611152

图片名称